Although we should consider these aspects in future works, the present study revealed that the main components of the ECS are already altered in APP/PS1 mice at the presymptomatic stage in a sex-dependent manner, suggesting that it could be an early event contributing to AD pathology, or a potential predictive biomarker. This evidence concerns the gene APP and Alzheimer disease.